| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Atara Biotherapeutics Inc | 1,063,189 | 56,094,000 | 18.70% | ||
| 2 | EPIZYME INC COM | 1,685,800 | 40,459,000 | 13.49% | ||
| 3 | ASSEMBLY BIOSCIENCES INC | 1,574,107 | 30,317,000 | 10.11% | ||
| 4 | FIBROGEN INC COM | 1,205,391 | 28,327,000 | 9.44% | ||
| 5 | ARRAY BIOPHARMA INC 3 06/01/2020 | 19,200,000 | 24,240,000 | 8.08% | PRN | |
| 6 | KITE PHARMA INCORPORATED | 281,400 | 17,157,000 | 5.72% | ||
| 7 | FLEX PHARMA INC COM | 908,691 | 15,629,000 | 5.21% | ||
| 8 | Life Technologies Corp | 836,860 | 15,499,000 | 5.17% | ||
| 9 | RETROPHIN INC COM | 341,650 | 11,326,000 | 3.78% | ||
| 10 | KINDRED BIOSCIENCES INC | 1,294,431 | 8,828,000 | 2.94% | ||
| 11 | COLLEGIUM PHARMACEUTICAL INC COM | 465,118 | 8,298,000 | 2.77% | ||
| 12 | ARRAY BIOPHARMA INC | 11,000 | 7,931,000 | 2.64% | Call | |
| 13 | OVASCIENCE INC | 2,300 | 6,654,000 | 2.22% | Call | |
| 14 | FORWARD PHARMA A/S | 158,985 | 6,049,000 | 2.02% | ||
| 15 | GENVEC INC | 1,986,413 | 4,052,000 | 1.35% | ||
| 16 | CELLADON CORP | 2,843,170 | 3,582,000 | 1.19% | ||
| 17 | CALITHERA BIOSCIENCES INC | 415,480 | 2,967,000 | 0.99% | ||
| 18 | ARRAY BIOPHARMA INC COM | 400,000 | 2,884,000 | 0.96% | ||
| 19 | Biotie Therapies Corp. | 100,000 | 1,997,000 | 0.67% | ||
| 20 | TARGACEPT INC | 619,699 | 1,729,000 | 0.58% | ||
| 21 | SERES THERAPEUTICS INC | 40,000 | 1,660,000 | 0.55% | ||
| 22 | QLT INC | 400,000 | 1,652,000 | 0.55% | ||
| 23 | REGULUS THERAPEUTICS INC | 1,280 | 1,403,000 | 0.47% | Call | |
| 24 | XENON PHARMACEUTICALS INC | 73,000 | 842,000 | 0.28% | ||
| 25 | EPIZYME INC | 150 | 360,000 | 0.12% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-031882, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
